Mylan N.V. (NASDAQ:MYL) was the recipient of unusually large options trading activity on Thursday. Stock traders bought 18,942 call options on the company. This is an increase of 589% compared to the typical volume of 2,749 call options.
Mylan N.V. (NASDAQ:MYL) traded up 0.52% during trading on Friday, hitting $30.72. The company’s stock had a trading volume of 7,185,271 shares. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $49.09. The firm has a 50 day moving average of $36.12 and a 200 day moving average of $38.80. The firm has a market cap of $16.47 billion, a P/E ratio of 24.83 and a beta of 1.27.
Mylan N.V. (NASDAQ:MYL) last posted its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The business had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period last year, the firm posted $1.16 earnings per share. Mylan N.V.’s quarterly revenue was up 15.7% on a year-over-year basis. Equities research analysts predict that Mylan N.V. will post $4.52 earnings per share for the current year.
In other news, President Rajiv Malik sold 25,000 shares of the business’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Anthony Mauro sold 10,000 shares of the business’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the completion of the sale, the insider now directly owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The disclosure for this sale can be found here. Insiders own 0.69% of the company’s stock.
Several large investors have recently added to or reduced their stakes in the stock. First Personal Financial Services raised its stake in Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock valued at $107,000 after buying an additional 681 shares in the last quarter. Global X Management Co. LLC raised its stake in Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock valued at $118,000 after buying an additional 1,441 shares in the last quarter. Ropes Wealth Advisors LLC purchased a new stake in Mylan N.V. during the first quarter valued at $136,000. Oakworth Capital Inc. raised its stake in Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock valued at $166,000 after buying an additional 1,000 shares in the last quarter. Finally, State of Alaska Department of Revenue purchased a new stake in Mylan N.V. during the first quarter valued at $188,000. Institutional investors own 71.57% of the company’s stock.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
What are top analysts saying about Mylan N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mylan N.V. and related companies.